1. Home
  2. MFC vs KTTA Comparison

MFC vs KTTA Comparison

Compare MFC & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Manulife Financial Corporation

MFC

Manulife Financial Corporation

HOLD

Current Price

$36.67

Market Cap

60.8B

Sector

Finance

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$1.17

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFC
KTTA
Founded
1887
2020
Country
Canada
United States
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.8B
5.3M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
MFC
KTTA
Price
$36.67
$1.17
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$52.00
$3.00
AVG Volume (30 Days)
2.0M
17.5M
Earning Date
11-12-2025
11-13-2025
Dividend Yield
3.40%
N/A
EPS Growth
10.85
N/A
EPS
2.24
N/A
Revenue
$22,912,074,891.00
N/A
Revenue This Year
$34.60
N/A
Revenue Next Year
$8.50
N/A
P/E Ratio
$15.92
N/A
Revenue Growth
6.09
N/A
52 Week Low
$25.92
$0.28
52 Week High
$36.93
$3.85

Technical Indicators

Market Signals
Indicator
MFC
KTTA
Relative Strength Index (RSI) 70.83 59.44
Support Level $36.08 $1.02
Resistance Level $35.61 $1.21
Average True Range (ATR) 0.45 0.09
MACD 0.05 -0.01
Stochastic Oscillator 87.59 50.22

Price Performance

Historical Comparison
MFC
KTTA

About MFC Manulife Financial Corporation

Manulife Financial is one of the Big Three Canadian life insurers. The firm provides life insurance, annuities, asset management, and wealth management products to individuals and group customers in Canada, the United States, and Asia. The Canadian business segment contributes approximately 22% of adjusted earnings. The Asia segment operates across 12 countries and contributes around 36% of earnings, with a significant presence in Hong Kong and Singapore. The US business, which primarily operates under the John Hancock brand, contributes about 23% of earnings. Manulife's global asset and wealth management business contributes approximately 20% of its earnings and had around CAD 1.03 trillion in assets under management and administration as of the end of 2024.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Share on Social Networks: